Food and Drug Administration (Taiwan)

Food and Drug Administration (Taiwan)
Agency name	Food and Drug Administration (Taiwan)
Nativename	衛生福利部食品藥物管理署
Formed	2013
Preceding1	Department of Health
Jurisdiction	Taiwan (Republic of China)
Headquarters	Taipei
Parent agency	Ministry of Health and Welfare

Food and Drug Administration (Taiwan) is the central administrative agency responsible for regulation of pharmaceuticals, medical devices, cosmetics, foodstuffs, and related public health matters under the Ministry of Health and Welfare (Taiwan). Established through institutional reform to consolidate oversight previously exercised by the Department of Health (Taiwan), the agency administers standards, licensing, inspection, and enforcement for products circulating in Taiwan, liaising with regional authorities such as the Taipei City Government and international partners including the World Health Organization and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

History

The agency traces roots to regulatory bodies within the Department of Health (Taiwan), evolving amid policy debates involving the Council of Agriculture (Taiwan), the Executive Yuan, and legislators from the Legislative Yuan. Responding to public concerns following high‑profile food and pharmaceutical incidents, reform initiatives led by the Ministry of Health and Welfare (Taiwan) culminated in establishment of a dedicated authority in 2013, modeled in part on institutions such as the United States Food and Drug Administration, the European Medicines Agency, and the Japan Pharmaceuticals and Medical Devices Agency. Subsequent milestones include adoption of new testing capacity influenced by partnerships with the Academia Sinica, accreditation efforts paralleling the Joint Commission International, and legislative revisions promoted by committees in the Legislative Yuan.

Organization and Structure

The agency operates as an organ subordinate to the Ministry of Health and Welfare (Taiwan), with organizational components reflecting functional domains: divisions for pharmaceuticals, medical devices, food safety, cosmetics, standards and testing, inspection and quarantine, and legal affairs. Regional administration coordinates with municipal entities such as the Kaohsiung City Government and the Taichung City Government, and technical bureaus collaborate with academic institutions including National Taiwan University and National Yang Ming Chiao Tung University. Leadership appointments are made through the Executive Yuan process, and advisory boards often include representatives from professional societies like the Taiwan Pharmacists Association and the Taiwan Medical Association.

Functions and Responsibilities

Primary responsibilities include premarket review, market surveillance, licensing, post‑market vigilance, recalls, and dissemination of consumer guidance. The agency issues approvals for products developed by domestic firms such as Taiwan Liposome Company and multinational corporations operating in Taiwan, enforces standards consistent with international regimes like the Codex Alimentarius Commission, and administers adverse event reporting systems interoperable with databases maintained by the World Health Organization. Enforcement actions may involve coordination with judicial bodies such as the Supreme Court of the Republic of China and prosecutor offices, while public communications engage media outlets such as the Central News Agency (Taiwan).

Regulatory Framework and Legislation

Regulatory authority rests on statutes enacted by the Legislative Yuan, including laws governing pharmaceuticals, medical devices, food safety, and cosmetics. The agency implements regulations aligned with frameworks from the World Trade Organization and bilateral arrangements negotiated by the Ministry of Economic Affairs (Taiwan). Key instruments mirror international guidance from bodies like the International Medical Device Regulators Forum and the Pharmacopeia Commission, while domestic enforcement refers to provisions in acts promulgated by the President of the Republic of China and adjudicated in courts such as the Taiwan High Court.

Drug and Medical Device Approval Processes

Premarket evaluation pathways distinguish between chemical pharmaceuticals, biologics, and in vitro diagnostics; procedures incorporate dossier review, clinical trial authorization, good manufacturing practice inspection, and risk/benefit assessment. Clinical trial oversight engages institutional review boards at hospitals like National Taiwan University Hospital and regulatory science collaborations with the Taiwan Food and Drug Administration Research Laboratories. Accelerated pathways and compassionate use protocols are informed by precedents from the European Medicines Agency and the U.S. Food and Drug Administration, while post‑approval pharmacovigilance is coordinated through adverse event reporting linked to networks including the World Health Organization’s Uppsala Monitoring Centre.

Food Safety and Inspection Programs

The agency administers food labeling, additive approvals, residue monitoring, and inspection programs for domestic production and imports, coordinating ports of entry with agencies such as the Bureau of Standards, Metrology and Inspection (Taiwan). Surveillance programs test for contaminants associated with incidents that have engaged civil society groups and legislators in the Legislative Yuan. Laboratory capacity is bolstered by cooperation with the Food and Drug Administration Research Laboratories and academic partners like National Chung Hsing University, and inspection protocols reference standards from the Codex Alimentarius Commission and regional agreements with partners such as Japan and South Korea.

International Cooperation and Agreements

The agency maintains technical exchanges and memoranda of understanding with counterparts including the U.S. Food and Drug Administration, the European Commission, the Japan Pharmaceuticals and Medical Devices Agency, and regulators in Australia and Singapore. Participation in fora like the International Council for Harmonisation and the International Medical Device Regulators Forum supports regulatory convergence, while bilateral agreements facilitate mutual recognition of inspections and data exchange. These partnerships underpin Taiwan’s role in global supply chains involving multinational corporations and strengthen emergency response coordination through links with the World Health Organization and regional public health agencies.

Category:Government agencies of Taiwan Category:Drug regulatory authorities Category:Food safety in Taiwan